Design of MDIs for Type 1 Diabetes Treatment via Rolling Horizon Cardinality-Constrained Optimisation

[1]  Ramón A. Delgado,et al.  A novel representation of rank constraints for real matrices , 2016 .

[2]  C. Cobelli,et al.  The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes , 2016, Diabetes Care.

[3]  Jon Lee,et al.  Optimal rank-sparsity decomposition , 2014, J. Glob. Optim..

[4]  W. Tamborlane,et al.  The Artificial Pancreas: Are We There Yet? , 2014, Diabetes Care.

[5]  C. Kenny.  When hypoglycemia is not obvious: diagnosing and treating under-recognized and undisclosed hypoglycemia. , 2014, Primary care diabetes.

[6]  W. Hellstrom.  Update on treatments for premature ejaculation , 2011, International journal of clinical practice.

[7]  T. Bailey,et al.  Guidelines for Optimal Bolus Calculator Settings in Adults , 2011, Journal of diabetes science and technology.

[8]  F. Doyle,et al.  Quest for the Artificial Pancreas: Combining Technology with Treatment , 2010, IEEE Engineering in Medicine and Biology Magazine.

[9]  Darrell M. Wilson,et al.  A Closed-Loop Artificial Pancreas Using Model Predictive Control and a Sliding Meal Size Estimator , 2009, Journal of diabetes science and technology.

[10]  C. Cobelli,et al.  Progress in Development of an Artificial Pancreas , 2009, Journal of diabetes science and technology.

[11]  P. Davidson,et al.  Analysis of guidelines for basal-bolus insulin dosing: basal insulin, correction factor, and carbohydrate-to-insulin ratio. , 2008, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[12]  A. King,et al.  A Prospective Evaluation of Insulin Dosing Recommendations in Patients with Type 1 Diabetes at near Normal Glucose Control: Basal Dosing , 2007, Journal of diabetes science and technology.

[13]  B. Bequette.  A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. , 2005, Diabetes technology & therapeutics.

[14]  S. Aronoff,et al.  Glucose Metabolism and Regulation: Beyond Insulin and Glucagon , 2004 .